Lifecore Biomedical, Inc. , together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Lifecore Biomedical stock last closed at $4.86, up 5.42% from the previous day, and has decreased 36.8% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.01 percentage points. Lifecore Biomedical stock is currently +34.07% from its 52-week low of $3.63, and -45.88% from its 52-week high of $8.98.
As of Jul 15, 2026, there are 37.51M LFCR shares outstanding. The market cap of LFCR is $182.30M. In the last 24 hours, 129,000 LFCR shares were traded.
You will need a brokerage account to access the NASDAQ market and buy LFCR stock.
We believe that eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, you'll need to fill out some personal details so you are able to buy LFCR today.
Now that you have finished signing up on one of the most highly reviewed stock apps, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing money into your brokerage account.
Once you have selected the best place to buy Lifecore Biomedical stock, it's very important to analyze their stock prior to investing, so you truly understand the risk and opportunity.
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on LFCR's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge LFCR's true value.
You can do additional valuation research on LFCR's stock here.
Out of 1 Wall Street analysts who give ratings on LFCR, the consensus analyst rating on LFCR is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Lifecore Biomedical stock forecast page.
Over the last 12 months, insiders at LFCR have sold more shares than they have bought.
Paul Josephs, Chief Executive Officer of LFCR, was the latest LFCR insider to sell. They sold $184,687.41 worth of LFCR shares on May 20, 2026.
Get more info about who owns LFCR shares here.
No, Lifecore Biomedical doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main options:
Press the Open Trade button and eToro will place your order.
If you need more info about investing in stocks on eToro, click the how to video below:
Now that you own some LFCR shares, you'll want to keep up with your new investment.
Put LFCR on a watchlist to keep track of your LFCR stock.
To reiterate, here are the 6 steps to buy stock in Lifecore Biomedical:
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Lifecore Biomedical, click the button below.